Herbas VPB

Print
EN | LT
LT - Pirolopiridino dariniai ir jų, kaip CRTH2 antagonistų, panaudojimas
EN - PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 471/04 (2006.01)
A61K 31/437 (2006.01)
European patent
(11) Number of the document 1761529
(13) Kind of document T
(96) European patent application number 05751627.0
Date of filing the European patent application 2005-06-16
(97) Date of publication of the European application 2007-03-14
(45) Date of publication and mention of the grant of the patent 2007-11-14
(46) Date of publication of the claims translation 2008-03-26
PCT application
(86) Number PCT/EP2005/006493
Date 2005-06-16
PCT application publication
(87) Number WO 2005/123731
Date 2005-12-29
Priority applications
(30) Number Date Country code
0413619 2004-06-17 GB
0507693 2005-04-15 GB
Inventors
(72)
BALA, Kamlesh, Novartis Horsham Research Centre, GB
LEBLANC, Catherine, Novartis Horsham Research Ctr., GB
SANDHAM, David Andrew, Novartis Horsham Res. Ctr., GB
TURNER, Katharine L., Novartis Horsham Res. Ctr., GB
WATSON, Simon James, Novartis Horsham Res. Ctr., GB
BROWN, Lyndon Nigel, GB
COX, Brian, Novartis Horsham Res. Ctr, GB
Grantee
(73) Novartis AG, Lichtstrasse 35, 4056 Basel, CH
Attorney or representative
(74) Marius JAKULIS - JASON, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Pirolopiridino dariniai ir jų, kaip CRTH2 antagonistų, panaudojimas
  PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS
Last renewal fee
Payment date Validity (years) Amount
2022-06-13 18 347.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2023-06-16